» Articles » PMID: 34605913

Systemic Sclerosis Sine Scleroderma in Children

Overview
Specialty Rheumatology
Date 2021 Oct 4
PMID 34605913
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Juvenile systemic sclerosis (JSSc) is a rare condition in childhood and its variety with no skin involvement, sine scleroderma (ssJSSc), is anecdotal. We report the first case series of patients with ssJSSc.

Methods: Demographic, clinical and laboratory data of patients with JSSc followed at our centre were retrospectively collected. Patients with no skin involvement but with all of the features RP, positive ANA, intestinal dysmotility and/or interstitial lung disease (ILD) or pulmonary arterial hypertension (PAH) and/or cardiac or renal involvement typical of scleroderma were defined as having ssJSSc and compared with those with classic JSSc (cJSSc).

Results: Among 52 JSSc patients seen in 20 years, five (9.6%) presented with ssJSSc. Their clinical features and those of the only two patients reported in the literature so far were compared with classic JSSc with available complete data. Six patients had cardiac involvement as presenting feature, three primary cardiomyopathy, three secondary to PAH. Two patients died after a brief disease course and one rapidly underwent heart transplantation. In comparison with cJSSc, ssJSSc showed a significantly longer diagnostic delay (20.1 vs 8.3 months, P = 0.017), higher frequency of cardiac involvement (85.7 vs 15.6%, P = 0.001) and worse outcome, intended as mortality or end-stage organ failure rates (42.9% vs 6.2%, P < 0.001).

Conclusion: Cardiac involvement represents the most important characteristic of ssJSSc and carries a high morbidity and mortality rate. The longer delay in diagnosis underlines the need for a comprehensive rheumatological work-up in patients with isolated cardiomyopathy or PAH/ILD.

Citing Articles

An updated overview of Juvenile systemic sclerosis in a French cohort.

Jacquel L, Bechara R, Terzic J, Rameau A, Chatelus E, Rossi-Semerano L Pediatr Rheumatol Online J. 2025; 23(1):13.

PMID: 39923051 PMC: 11807294. DOI: 10.1186/s12969-024-01043-6.


Cardiovascular risk and inflammation in a population with autoimmune diseases: a narrative review.

Bertoni C, Mazzocchi A, Leone L, Agostoni C, Filocamo G Front Immunol. 2024; 15:1380372.

PMID: 38605945 PMC: 11006973. DOI: 10.3389/fimmu.2024.1380372.


A case report of clubbing as the initial sign of systemic sclerosis sine scleroderma: A rare possible presentation.

Amirpour A, Ghorbani P, Ghadirzadeh E, Charkazi E, Paraandavaji E Clin Case Rep. 2023; 11(10):e8090.

PMID: 37867549 PMC: 10587653. DOI: 10.1002/ccr3.8090.

References
1.
Marangoni R, Rocha L, Del Rio A, Yoshinari N, Marques-Neto J, Sampaio-Barros P . Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort. Rheumatology (Oxford). 2013; 52(8):1520-4. DOI: 10.1093/rheumatology/ket163. View

2.
Civieri G, Castaldi B, Martini G, Meneghel A, Milanesi O, Zulian F . Early detection of ventricular dysfunction in juvenile systemic sclerosis by speckle tracking echocardiography. Rheumatology (Oxford). 2020; 60(1):103-107. PMC: 7785305. DOI: 10.1093/rheumatology/keaa208. View

3.
Denton C, Khanna D . Systemic sclerosis. Lancet. 2017; 390(10103):1685-1699. DOI: 10.1016/S0140-6736(17)30933-9. View

4.
Zulian F, Woo P, Athreya B, Laxer R, Medsger Jr T, Lehman T . The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum. 2007; 57(2):203-12. DOI: 10.1002/art.22551. View

5.
Allanore Y, Distler O, Matucci-Cerinic M, Denton C . Review: Defining a Unified Vascular Phenotype in Systemic Sclerosis. Arthritis Rheumatol. 2017; 70(2):162-170. DOI: 10.1002/art.40377. View